CORE
🇺🇦Â
 make metadata, not war
Services
Services overview
Explore all CORE services
Access to raw data
API
Dataset
FastSync
Content discovery
Recommender
Discovery
OAI identifiers
OAI Resolver
Managing content
Dashboard
Bespoke contracts
Consultancy services
Support us
Support us
Membership
Sponsorship
Community governance
Advisory Board
Board of supporters
Research network
About
About us
Our mission
Team
Blog
FAQs
Contact us
Comparative Effects of LY3020371, a Potent and Selective Metabotropic Glutamate (mGlu) 2/3 Receptor Antagonist, and Ketamine, a Noncompetitive N
Authors
A. Nikolayev
Ago
+37Â more
B.J. Eastwood
C. Overshiner
C.H. Mitch
Cartmell
Chappell
da Silva
Dunayevich
Fitzgerald
G. Carter
G. Gilmour
Gleason
Greco
Helton
J. Li
J.A. Monn
J.M. Witkin
J.T. Catlow
K. Rasmussen
K.A. Wafford
L. Rorick-Kehn
M.-S. Kuo
Monn
Neugebauer
Nisenbaum
Olive
P.L. Ornstein
Patil
Popp
R. Li
S. Swanson
S.C. Smith
S.N. Mitchell
Seidel
V.V. Tolstikov
Van Gelder
W.H. Anderson
X. Li
Publication date
Publisher
'American Society for Pharmacology & Experimental Therapeutics (ASPET)'
Doi
Cite
Abstract
Abstract is not available.
Similar works
Full text
Available Versions
Crossref
See this paper in CORE
Go to the repository landing page
Download from data provider
info:doi/10.1124%2Fjpet.116.23...
Last time updated on 14/11/2020
